Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1992-10-1
|
pubmed:abstractText |
The authors report a case of acute cardiac failure linked to 5 fluoro-uracil. The toxicity seen most commonly involves ischemia. The pathophysiological mechanisms are discussed as well as the role played by pharmacokinetic characteristics in the occurrence of adverse reactions. 5 fluoro-uracil (5 FU) is a compound widely used in the treatment of ENT, breast and gastrointestinal carcinomas. The finding of dose-effect relationship may lead the clinician to use different modes of administration. Continuous administration at high dose 3 g/m2/day from D1 to D5) in combination or not with cisplatin, or continuously at low dose (300 mg/m2/day from D1 to D31) can reduce hematopoietic toxicity but, in contrast, increases gastrointestinal toxicity.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0066-2070
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
117-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1514765-Adenocarcinoma,
pubmed-meshheading:1514765-Cardiac Output, Low,
pubmed-meshheading:1514765-Digoxin,
pubmed-meshheading:1514765-Diuretics,
pubmed-meshheading:1514765-Echocardiography, Doppler,
pubmed-meshheading:1514765-Electrocardiography,
pubmed-meshheading:1514765-Female,
pubmed-meshheading:1514765-Fluorouracil,
pubmed-meshheading:1514765-Humans,
pubmed-meshheading:1514765-Middle Aged,
pubmed-meshheading:1514765-Sigmoid Neoplasms
|
pubmed:articleTitle |
[A case of acute cardiac insufficiency caused by 5-fluorouracil].
|
pubmed:affiliation |
Service d'Hépatogastroentéroligie, Hôpital Manchester, Charleville-Mezières.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review,
Case Reports
|